Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$86.42 - $109.81 $5,703 - $7,247
-66 Closed
0 $0
Q3 2021

Nov 24, 2021

SELL
$91.91 - $110.37 $2,389 - $2,869
-26 Reduced 28.26%
66 $7,000
Q1 2021

Apr 29, 2021

SELL
$71.83 - $95.48 $9,625 - $12,794
-134 Reduced 59.29%
92 $8,000
Q4 2020

Jan 15, 2021

BUY
$67.0 - $84.39 $15,142 - $19,072
226 New
226 $17,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.